Bank of New York Mellon
KMTS

Bank of New York Mellon’s Kestra Medical Technologies KMTS Stock Holding History

Bank of New York Mellon’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.89M Buy
74,184
+4,071
+6% +$85.2K ﹤0.01% 2984
2026
Q1 		$1.4M Buy
70,113
+22,471
+47% +$530K ﹤0.01% 3007
2025
Q4 		$1.26M Buy
47,642
+13,917
+41% +$358K ﹤0.01% 3105
2025
Q3 		$801K Buy
33,725
+789
+2% +$14.1K ﹤0.01% 3340
2025
Q2 		$546K Buy
+32,936
New +$719K ﹤0.01% 3463

Other funds holding KMTS

AP
Andera Partners Paris $206M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
SWASL
Spartan Wealth Advisory Services LLC Bingham Farms, Michigan $1.22B AUM
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Bank of New York Mellon's KMTS Position: Q2 2026 in Review

Bank of New York Mellon increased its Kestra Medical Technologies (KMTS) stake by 5.8% in Q2 2026, buying an estimated $85.2K and bringing the position to 74,184 shares worth $1.89M. The position accounts for ﹤0.01% of the portfolio, ranked #2984.

Bank of New York Mellon first reported a position in KMTS in Q2 2025 and has held it in 5 quarters since. 39 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • Bank of New York Mellon held 74,184 shares of Kestra Medical Technologies worth $1.89M as of Q2 2026.
  • Bank of New York Mellon bought 4,071 Kestra Medical Technologies shares in Q2 2026, an estimated $85.2K.
  • Kestra Medical Technologies made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2984 holding.
  • Bank of New York Mellon first reported a position in Kestra Medical Technologies in Q2 2025 and has held it in 5 quarters since.
  • 39 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.